341 results
424B7
EXAS
Exact Sciences Corp.
8 May 24
Prospectus with selling stockholder info
5:08pm
and maintenance of adequate reimbursement rates for our products and services within and outside of the U.S.; the amount and nature of competition for our … that will be submitted to MolDx for approval and subsequent Medicare reimbursement. In June 2023, we entered into a sponsored research agreement and exclusive
8-K
EX-99.1
EXAS
Exact Sciences Corp.
8 May 24
Exact Sciences Announces First-Quarter 2024 Results
4:08pm
that are the sole source of certain supplies and products used in our tests and operations; approval and maintenance of adequate reimbursement rates
8-K
EX-99.1
id54h8n5g8v5x2jn7i5i
21 Feb 24
Exact Sciences Announces Fourth Quarter 2023 Results
4:40pm
8-K
EX-99.1
ejnh6 mdixud
21 Jun 23
Regulation FD Disclosure
10:33am
8-K
EX-3.2
9ag6n0 7p7
12 Jun 23
Material Modifications to Rights of Security Holders
6:00am
8-K
EX-10.1
kf7qs9
30 Jun 22
Entry into a Material Definitive Agreement
7:34am
DEFA14A
0z3f0f a345
20 May 22
Additional proxy soliciting materials
11:24am
424B7
ze6mmymyamxenj664
2 May 22
Prospectus with selling stockholder info
4:01pm